SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as investors eagerly await topline results from its pivotal Phase 3 superiority trial of Axpaxli in wet AMD, scheduled for release Tuesday. The community is actively discussing strong expectations for the data, fueled by potential buyout rumors from Sanofi and the prospect of the drug redefining long-acting retinal therapy.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares

LABU is trending as the biotech sector sees a robust rally, driven by optimistic outlooks on AI advancements in drug discovery and anticipation of Fed rate cuts, while investors actively debate the sustainability of this strong upward momentum.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bear 3X Shares

LABD is trending as the biotech sector (XBI) continues its surprising upward momentum, pushing past anticipated resistance levels and fueling intense debate among investors who see unsustainable technicals and await a significant correction. The community is actively discussing whether XBI's prolonged rally is nearing a reversal point, as broader market uncertainty and recent biotech buyouts contribute to a complex outlook.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line Holdings is trending due to activist investor Elliott Management taking a significant stake, which is fueling community optimism for strategic changes to improve performance and close the gap with rivals amidst broader discussions of past underperformance and alleged market manipulation.

United Parcel Service, Inc. is a package delivery company, which engages in the provision of global supply chain management solutions. It operates through the following segments: U.S. Domestic Package, International Package, and Supply Chain Solutions. The U.S. Domestic Package segment includes time-definite delivery of letters, documents, and packages. The International Package segment focuses on delivery and shipments in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The Supply Chain Solutions is involved in forwarding, logistics, Coyote, Marken, and UPS Mail Innovations. The company was founded by James E. Casey and Claude Ryan on August 28, 1907 and is headquartered in Atlanta, GA.

United Parcel Service, Inc. - Ordinary Shares - Class B

United Parcel Service, Inc.

UPS is trending as investors react to its recent earnings, which featured optimistic guidance and strategic job cuts aimed at boosting margins by reducing Amazon volume. This positive outlook is being weighed against immediate concerns surrounding a fatal cargo plane crash and subsequent aircraft groundings, sparking community discussion over long-term strategy, operational risks, and the stock's dividend appeal.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM Integrated Shipping Services is trending as Hapag-Lloyd has announced a definitive agreement to acquire the company for $35 per share, generating excitement around the significant premium and potential for a short squeeze. The community is actively discussing the deal's finalization, anticipating regulatory approval from the Israeli government, and speculating on potential dividends until the expected late 2026 closing.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Infleqtion Inc. - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X (CCCX) is trending amidst high anticipation for its merger with quantum technology leader Infleqtion, poised to debut on the NYSE as INFQ. The exceptionally low redemption rate signals strong investor confidence, with the community actively discussing Infleqtion's "best in class" quantum computing and sensing capabilities, bolstered by significant government contracts.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean (RIG) is trending sharply higher after announcing an all-stock acquisition of Valaris (VAL), forming a major offshore drilling leader with an expanded fleet and backlog. This is leading the community to anticipate increased pricing power and a potential short squeeze amid strong energy sector tailwinds.

Barclays Bank Plc engages in providing commercial banking services. It offers personal, premier, business, and corporate banking products and services to its customers. Its services include current accounts, savings, investments, mortgages, loans, insurance, credit cards, and online banking. The company was founded on October 4, 1971 and is headquartered in London, the United Kingdom.

Barclays Bank PLC - iPathÂ® Series B S&P 500Â® VIX Short-Term FuturesTM ETN

iPath S&P 500 VIX Short-Term Futures ETN

VXX BATS is experiencing heightened interest as traders actively hedge against potential market volatility. Community discussions highlight large VIX call purchases, upcoming economic data, and geopolitical concerns as immediate catalysts for a projected market pullback.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending amid escalating speculation of a potential acquisition by major tech players like SpaceX or Amazon, fueled by its uniquely valuable n53 spectrum and expanding role in direct-to-device connectivity with Apple, Boingo, and drone applications. The community is eagerly anticipating key FCC decisions regarding spectrum use and the deployment of its C-3 constellation, which are seen as critical catalysts to unlock the company's perceived undervaluation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives Average Recommendation of "Moderate Buy" from Analysts

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the seven brokerages that are currently covering the stock, MarketBeat Ratings...

Esperion Therapeutics (NASDAQ:ESPR) Downgraded by Wall Street Zen to "Hold"

Wall Street Zen downgraded Esperion Therapeutics from a "buy" rating to a "hold" rating in a research report on Saturday...

Zacks Research Issues Optimistic Forecast for ESPR Earnings

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Free Report) - Analysts at Zacks Research upped their Q4 2025 earnings estimates for Esperion Therapeutics in a research report issued on Tuesday, February...

Esperion Therapeutics (NASDAQ:ESPR) Raised to "Buy" at Wall Street Zen

Wall Street Zen raised Esperion Therapeutics from a "hold" rating to a "buy" rating in a research report on Saturday...

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Given Average Recommendation of "Moderate Buy" by Brokerages

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) has received a consensus rating of "Moderate Buy" from the eight ratings firms that are currently covering the company, Marketbeat.com...

Esperion Therapeutics (NASDAQ:ESPR) Shares Gap Down - Should You Sell?

Esperion Therapeutics (NASDAQ:ESPR) Shares Gap Down - Should You Sell...

What is HC Wainwright's Estimate for ESPR FY2025 Earnings?

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Free Report) - Stock analysts at HC Wainwright upped their FY2025 earnings per share (EPS) estimates for Esperion Therapeutics in a note issued to investors...

Esperion Therapeutics (NASDAQ:ESPR) Shares Down 6.3% - Here's Why

Esperion Therapeutics (NASDAQ:ESPR) Shares Down 6.3% - Here's Why...

Esperion Therapeutics (NASDAQ:ESPR) Sets New 12-Month High - Here's Why

Esperion Therapeutics (NASDAQ:ESPR) Reaches New 1-Year High - Should You Buy...

Esperion Therapeutics (NASDAQ:ESPR) Upgraded by Wall Street Zen to "Buy" Rating

Wall Street Zen upgraded shares of Esperion Therapeutics from a "hold" rating to a "buy" rating in a research note on Saturday...

Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.

Esperion Therapeutics Inc.

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

Current Price	$3.43
Prev Close	$3.40
Open	$3.40
Dividend Yield	0.00%
50-Day Moving Average	$3.59
Beta	1.19
Avg. Volume	5.8M
PE Ratio	-6.40

52-Week High	$4.18
52-Week Low	$0.6925
Market Capitalization	$826.83M
EPS (Annual)	-$0.2764
Price to Book	-1.56
Revenue Per Employee	$1.09M

ESPR
Esperion Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ESPR News

ESPREsperion Therapeutics Inc.